Fidelity Investments’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$131K Sell
3,223
-657
-17% -$26.7K ﹤0.01% 3486
2025
Q1
$170K Hold
3,880
﹤0.01% 3314
2024
Q4
$167K Buy
3,880
+107
+3% +$4.6K ﹤0.01% 3340
2024
Q3
$167K Hold
3,773
﹤0.01% 3252
2024
Q2
$150K Buy
3,773
+13
+0.3% +$517 ﹤0.01% 3142
2024
Q1
$162K Buy
3,760
+56
+2% +$2.42K ﹤0.01% 3100
2023
Q4
$154K Buy
3,704
+659
+22% +$27.4K ﹤0.01% 3038
2023
Q3
$121K Sell
3,045
-4
-0.1% -$159 ﹤0.01% 3040
2023
Q2
$125K Sell
3,049
-32
-1% -$1.31K ﹤0.01% 3087
2023
Q1
$126K Buy
3,081
+119
+4% +$4.88K ﹤0.01% 3126
2022
Q4
$121K Sell
2,962
-371
-11% -$15.2K ﹤0.01% 3141
2022
Q3
$134K Buy
3,333
+2,874
+626% +$116K ﹤0.01% 3180
2022
Q2
$19K Buy
459
+176
+62% +$7.29K ﹤0.01% 3904
2022
Q1
$13K Hold
283
﹤0.01% 4175
2021
Q4
$13K Buy
283
+1
+0.4% +$46 ﹤0.01% 3585
2021
Q3
$13K Sell
282
-1
-0.4% -$46 ﹤0.01% 3555
2021
Q2
$15K Sell
283
-108
-28% -$5.72K ﹤0.01% 3466
2021
Q1
$20K Buy
391
+108
+38% +$5.52K ﹤0.01% 3250
2020
Q4
$15K Sell
283
-159
-36% -$8.43K ﹤0.01% 3238
2020
Q3
$19K Buy
442
+251
+131% +$10.8K ﹤0.01% 3066
2020
Q2
$8K Sell
191
-226
-54% -$9.47K ﹤0.01% 3167
2020
Q1
$15K Sell
417
-660
-61% -$23.7K ﹤0.01% 3020
2019
Q4
$49K Buy
1,077
+895
+492% +$40.7K ﹤0.01% 2898
2019
Q3
$6K Sell
182
-134
-42% -$4.42K ﹤0.01% 3374
2019
Q2
$13K Buy
316
+1
+0.3% +$41 ﹤0.01% 3184
2019
Q1
$13K Sell
315
-533
-63% -$22K ﹤0.01% 3077
2018
Q4
$31K Sell
848
-214
-20% -$7.82K ﹤0.01% 2819
2018
Q3
$52K Buy
+1,062
New +$52K ﹤0.01% 2825
2015
Q4
Sell
-4,265
Closed -$200K 2781
2015
Q3
$200K Buy
4,265
+153
+4% +$7.18K ﹤0.01% 2684
2015
Q2
$251K Buy
4,112
+838
+26% +$51.2K ﹤0.01% 2680
2015
Q1
$205K Buy
+3,274
New +$205K ﹤0.01% 2717
2014
Q3
Sell
-662,176
Closed -$34.4M 2832
2014
Q2
$34.4M Buy
662,176
+240,460
+57% +$12.5M ﹤0.01% 1530
2014
Q1
$19.8M Sell
421,716
-858,600
-67% -$40.2M ﹤0.01% 1758
2013
Q4
$56.3M Buy
+1,280,316
New +$56.3M 0.01% 1256
2013
Q3
Sell
-1,192,934
Closed -$42M 2682
2013
Q2
$42M Buy
+1,192,934
New +$42M 0.01% 1329